Invivyd, Inc. (IVVD)

NASDAQ: IVVD · Real-Time Price · USD

0.8918

+0.0232 (2.67%)

At close: Jun 16, 2026, 4:00 PM EDT

0.8851

-0.0067 (-0.75%)

After-hours: Jun 16, 2026, 7:25 PM EDT

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Discovery, Development and Commercialization of Antibody-Based Solutions	53.43M	25.38M	-	-	-
Discovery, Development and Commercialization of Antibody-Based Solutions Growth	110.47%	-	-	-	-
Total	53.43M	25.38M	-	-	-
Total Growth	110.47%	-	-	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
United States	53.43M	25.38M	-	-	-
United States Growth	110.47%	-	-	-	-
Total	53.43M	25.38M	-	-	-
Total Growth	110.47%	-	-	-	-